Valuation: Haleon plc

Market Cap 30.01B 40.14B 35B 33.05B 56.23B 3,852B 56.47B 396B 153B 1,958B 151B 147B 6,301B P/E 2026 *
17.7x
P/E 2027 * 15.7x
Enterprise Value 36.91B 49.37B 43.05B 40.65B 69.16B 4,737B 69.45B 487B 188B 2,408B 185B 181B 7,750B EV / Sales 2026 *
3.24x
EV / Sales 2027 * 3.06x
Free-Float
98.46%
Yield 2026 *
2.37%
Yield 2027 * 2.62%

Last Transcript: Haleon plc

1 day+0.29%
1 week+2.07%
Current month-7.47%
1 month-4.19%
3 months+2.07%
6 months-11.78%
Current year-9.10%
1 week 336.1
Extreme 336.1
345.9
1 month 333
Extreme 333
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+2.07%+0.18%+3.98% 40.14B
+0.04%+3.34%+51.12%+101.82% 1,028B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 466B
-1.22%+3.66%+36.44%+38.32% 346B
-0.79%+2.73%+19.03%+25.08% 266B
+0.58%+6.76%+11.13%+16.52% 259B
+1.55%+2.20%+39.81%+46.55% 208B
+0.79%+1.84%-28.27%-56.71% 191B
-0.52%+4.45%+32.12%+98.51% 186B
Average +0.21%+3.14%+23.55%+41.17% 364.19B
Weighted average by Cap. +0.23%+3.08%+34.76%+61.13%

Financials

2026 *2027 *
Net sales 11.39B 15.23B 13.28B 12.54B 21.33B 1,461B 21.42B 150B 57.96B 743B 57.2B 55.93B 2,390B 11.86B 15.86B 13.83B 13.06B 22.22B 1,522B 22.31B 156B 60.36B 774B 59.58B 58.25B 2,490B
Net income 1.69B 2.27B 1.98B 1.87B 3.17B 217B 3.19B 22.34B 8.62B 111B 8.51B 8.32B 356B 1.91B 2.56B 2.23B 2.11B 3.59B 246B 3.6B 25.24B 9.74B 125B 9.61B 9.4B 402B
Net Debt 6.9B 9.23B 8.05B 7.6B 12.93B 886B 12.98B 91.03B 35.13B 450B 34.67B 33.9B 1,449B 6.3B 8.42B 7.34B 6.93B 11.8B 808B 11.85B 83.06B 32.05B 411B 31.64B 30.93B 1,322B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-18 GBX 340.70 +0.29% 63,916,336
26-09-17 GBX 339.70 -0.03% 41,125,485
26-09-16 GBX 339.80 -0.21% 13,491,029
26-09-15 GBX 340.50 -0.50% 23,713,207
26-09-14 GBX 342.20 +2.52% 24,907,764
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.407GBP
Average target price
4.202GBP
Spread / Average Target
+23.34%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!